Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin Eye Drops (II) for Dry Eye – Phase IV Safety and Effectiveness Study
CTR20230929Phase 4Active
- Sponsor
- Xingqi Eye Medicine
- Start
- Mar 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in dry eye syndrome (DED), sponsored by Xingqi Eye Medicine. Started Mar 2023; status: active.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20230929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230929.